ViraTree

ViraTree is a private, early-stage biotech company operating as a specialized supplier of research tools for the infectious disease and vaccine development sectors. Its core business involves the production and sale of ready-to-use, reporter-tagged respiratory viruses (e.g., RSV, parainfluenza, MPV) that enable advanced study of viral infection dynamics, tropism, and therapeutic interventions. The company complements its product catalog with custom virus preparation services and a unique 'Virus Deposit' platform, allowing researchers to commercialize their proprietary viral constructs. ViraTree appears to be in an early revenue-generating phase, serving a global research community from its BSL-2 certified biocontainment labs.

Genetic engineering platform for creating recombinant respiratory viruses (e.g., RSV, parainfluenza, metapneumovirus) stably expressing reporter genes (GFP, RFP, Luciferase) for real-time visualization and tracking of viral infection in research settings.

ViraTree competes in the niche market for engineered virology research tools. Direct competitors include academic core facilities that produce similar reagents and large biological resource centers like ATCC, which may offer some wild-type and modified viruses. Differentiation is achieved through specialization in ready-to-use, reporter-tagged respiratory viruses, a focused catalog, and the unique virus deposit/sharing service model.